View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
September 2021
News | Clinical knowledge summaries | Into practice | Events | Blogs | Get involved | Announcements


Inclisiran box and syringe

Final draft guidance approves cholesterol-lowering drug inclisiran

We’ve issued final draft guidance recommending inclisiran for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke. It can be used on its own or alongside statins or other cholesterol lowering drugs.

Swollen knee from juvenile arthritis

New treatment for people with juvenile idiopathic arthritis

We’ve recommended tofacitinib as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people aged 2 years and older. Juvenile idiopathic arthritis is an inflammation of the joints that begins in children under 16 years of age. More than 1,000 people in England will be eligible for treatment.

New guideline on babies, children and young people’s experience of healthcare

Our new guideline emphasises the need to provide children and young people with clear and accurate information which can be tailored to an individual patient’s level of maturity and understanding. Information materials should be developed in partnership with young people and presented in a range of formats using words and images.

Catch up on all our latest news articles

Clinical knowledge summaries

New topics and updates on the site since the start of September include:

Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

Impact report highlights progress and innovations in CVD prevention

Our latest impact report on preventing cardiovascular disease (CVD)  details progress made by the health and care system in implementing NICE guidance on the topic. It highlights areas of progress, innovation and challenge, including examples from the COVID-19 pandemic.

Read CVD prevention impact report


Methods and process review webinar: a focus on MedTech 

Register for our webinar to find out what proposed changes to our methods and processes of health technology evaluation mean for MedTech developers and the patients who use their products.

  • Thursday 7 October 2021, 11am-12pm on Zoom.
Register for our webinar

World Evidence-Based Healthcare (EBHC) Day: the role of evidence in an infodemic

World EBHC Day takes place on Wednesday 20 October 2021. In response to the World Health Organization's call for action on infodemic management, this year's theme is ‘the role of evidence in an infodemic’. 

NICE and 6 other global leaders in evidence-based healthcare will run a series of events throughout the day. 

Find out more about World EBHC Day


Aishah Farooq, lay member of the NICE guideline committee

Hearing the voices of young patients

Aishah Farooq sat as a lay member on the committee that developed our babies, children and young people’s experience of healthcare guideline. She tells us why it’s important for everyone to recognise that babies, children, young people and their families have a choice and a voice when accessing healthcare.

Read more of our latest blog posts

Get involved

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for health, social care and other professionals and practitioners to join our:

Our guidance and quality standards are developed by independent committees. Join us and have an active role in producing a guideline or quality standard.
See all our committee vacancies


Professor Gillian Leng

Professor Gillian Leng to retire from NICE

NICE chief executive, Professor Gillian Leng, has announced she is to retire from NICE. Professor Leng, who has worked at NICE for over 20 years, is departing to pursue new challenges. Details on recruitment of a successor will follow in due course.

NICE and Cochrane sign collaborative agreement to deliver ‘living’ guideline recommendations

We’ve signed a collaborative agreement with Cochrane that will help us to deliver ‘living’ recommendations across our guideline portfolio. The agreement will enable us to better use Cochrane reviews in responding to changes in the evidence. This will allow us to make efficient and effective updates to the recommendations in our guidelines, thereby supporting one of our core strategic objectives to provide living guideline recommendations that are dynamic and rapidly updated.

ME/CFS guideline roundtable discussion announced

We recently paused publication of our updated guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This decision followed issues raised by some professional groups during the pre-publication period. To fully understand the health professionals’ concerns, we are holding a roundtable meeting to discuss the updated guideline and the issues raised on Monday 18 October. NICE has invited relevant professional organisations, plus representatives from interested patient groups, to attend. The discussion will help to inform NICE’s thinking on the next steps for publication of the guideline.


unsubscribe from this list